Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1719 of 6351
-
New psoriasis pill tested for Long-Term safety in thousands of patients
Disease control OngoingThe main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on deadliest brain cancer
Disease control Recruiting nowThis is a phase I, open-Label, single/multiple dose, dose-escalation study to evaluate the safety, tolerability and antitumor activity of anti-B7-H3 CAR-T cell injection (TX103) in subjects with recurrent or progressive Grade 4 Glioma.The study also plan to explore the Maximum To…
Phase 1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Your own blood may be the key to easier wisdom tooth recovery
Symptom relief Recruiting nowThis prospective, randomized interventional study aims to compare the postoperative effects of standard treatment (control), platelet-rich fibrin (PRF), and PRF combined with corticosteroid treatment in patients undergoing impacted mandibular third molar surgery. A total of 60 pa…
Sponsor: Final International University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New antibody takes on Hard-to-Treat myeloma
Disease control OngoingA Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (anti-MICA/MICB Antibody) in Patients with Relapsed and Refractory Multiple Myeloma
Phase 1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Could early use of a 'Smart' stimulator tame CRPS pain?
Symptom relief Recruiting nowThe primary purpose of this study is to determine the differences in response to treatment of complex regional pain syndrome with a closed-loop spinal cord stimulator if applied in the early phases (acute or subacute) versus the chronic phase.
Sponsor: Scripps Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New Once-Daily pill could ease Post-Surgery pain
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a Abdominoplasty.
Phase 3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Metal mesh implanted in eye could halt keratoconus
Disease control Recruiting nowThis Study is a First In Human clinical investigation addressed to evaluate the safety and efficacy of a novel intra-corneal nitinol device (Investigational Medical Device: GROSSO® implant) for the treatment of advanced keratoconus disease of the eye.
Sponsor: Recornea Srl • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cash for quitting: Family-Based incentives aim to help alaska natives kick the habit
Disease control Recruiting nowThe current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Experimental vaccine fights sarcoma with Patient's own immune cells
Disease control Recruiting nowThe primary objective of this trial is to evaluate the safety and tolerability of the tumor neoantigen vaccine (SarcVac) in combination with a PD-1 antibody, with or without tumor-specific lymphocytes, in patients with advanced bone and soft tissue sarcoma who have failed first-l…
Phase 1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New inhaled drug shows promise for Long-Term control of rare lung disease
Disease control Recruiting nowThis open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study
Phase 3 • Sponsor: Gossamer Bio USA, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New blood filter aims to speed recovery in ICU patients on life support
Disease control Recruiting nowPatients who are very ill either due to a severe infection, major organ injury, trauma or a major operation may require significant support with devices such as a dialysis machine for the kidneys or Extracorporeal Membrane Oxygenation (ECMO) for the heart and lungs. This is often…
Sponsor: University Hospitals, Leicester • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can eye movements heal trauma in schizophrenia? new trial investigates
Symptom relief Recruiting nowSchizophrenia spectrum disorders (SSDs) have a significant trauma etiology: trauma has been reported in 65 - 80% in this patient group and have a negative impact on prognosis. Trauma treatment is currently not offered in SSDs due to a lack of evidence. KIT is a pragmatic trial co…
Sponsor: Haukeland University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
A drug that may speed platelet recovery after stem cell transplants in kids
Disease control CompletedThe objective of this observational study is to explore the long-term effects of roprastine given to promote platelet implantation in hematopoietic stem cell hemicongruent transplantation in children with thalassemia. The main questions it aimed to answer is: Is roprastine safe …
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a dye reveal hidden scarring in Crohn's patients?
Knowledge-focused Recruiting nowCrohn's Disease (CD) is a chronic inflammatory condition that can affect any part of the intestine and currently has no cure. It affects 6.8 million people worldwide with UK healthcare costs in excess of £1 billion per year. Recent data suggests that the despite significant progr…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Green tea extract tested to stop liver cancer before it starts
Prevention Recruiting nowThis phase II trial tests epigallocatechin gallate (EGCG) for its efficacy and safety in preventing development of hepatocellular carcinoma (HCC) in patients with liver cirrhosis.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 26, 2026 14:16 UTC
-
Could zinc and a liver pill help newborns beat jaundice faster?
Disease control Recruiting nowNeonatal jaundice, or neonatal hyperbilirubinemia, is a common medical issue in the first two weeks of life, causing prolonged hospitalization and readmissions. It results from elevated total serum bilirubin (TSB) and is manifested as yellowish discoloration of the skin, sclera, …
Phase 4 • Sponsor: Amira Adel Fouly • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Brain zaps to kick the habit: TMS trial targets smokers with mental health struggles
Disease control Recruiting nowTobacco smoking is the leading preventable cause of morbidity and mortality worldwide. However, currently available treatments, including standard pharmacotherapy and behavioural support, are limited in their efficacy, tolerability, and acceptability by patients. Additionally, to…
Phase 4 • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy targets Hard-to-Treat rheumatoid arthritis
Disease control Recruiting nowRheumatoid arthritis (RA) is the leading cause of disability in Chinese women. We established a synovial pathology queue in the early stage and proposed a new synovial immunopathology classification. We found that baseline myeloid stromal RA patients had severe conditions and poo…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Community health workers lead push to cut heart disease in pasifika communities
Disease control CompletedNative Hawaiians and Pacific Islanders (NHPIs) are defined as the descendants of the original peoples of Polynesia (e.g., Hawai'i, Sāmoa, and Tonga), Melanesia (e.g., Fiji), and Micronesia (e.g., Guam, Chuuk, and Marshall Islands). Their history with the U.S. parallels that of Am…
Sponsor: University of Hawaii • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill could help regrow hair in alopecia areata patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of NXC-736 monotherapy in participants with severe alopecia areata (AA).
Phase 2 • Sponsor: NEXTGEN Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC